Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience

American Journal of Medicine

Volumn 102, Issue 2, 1997, Pages 192-199

  Waked, Imam ^a   Korula, Jacob ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METHYLENE BLUE; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REIMBURSEMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COSTS; HUMANS; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; RECURRENCE; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 0030947788     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00401-9     Document Type: Article

References (24)

1. Terblanche J, Burroughs AK, Hobbs KEF. Controversies in the management of bleeding esophageal varices. NEJM. 1989;320:1469-1475.
2. Korula J, Balart L, Radvan G, Yamada S. A prospective randomized controlled trial of chronic sclerotherapy. Hepatology. 1985;5:584-589.
3. MacDougall BRD, Westaby D, Theodossi A, et al. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982;1:124-127.
4. Westaby D, Williams R. Improved survival following injection sclerotherapy for esophageal varices. Final analysis of controlled trial. Hepatology. 1985;5:827-830.
5. Russo A, Magnano A, Passanisi G, Giannone N. Endoscopic esophageal sclerotherapy: long-term results of the elective procedure. Dig Dis. 1992;10(suppl 1):65-73.
6. Kitano S, Koyanagi N, Iso Y, et al. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology. 1987;7:810-815.
7. Korula J, Baydur A, Sassoon C, Sakimura I. The effect of esophageal variceal sclerotherapy on lung function. A prospective controlled study. Arch Intern Med. 1986;146:1517-1520.
8. Akriviadis E, Korula J, Gupta S, et al. A prospective randomized controlled comparison of two treatment schedules of endoscopic variceal sclerotherapy. Dig Dis Sci. 1989;9:363-366.
9. Larson AW, Cohen H, Zweiban B, et al. Acute esophageal variceal sclerotherapy: results of a prospective randomized controlled trial. JAMA. 1986;255: 497-500.
10. Terblanche J, Bornman PC, Kahn D, et al. Failure of repeated injection sclerotherapy to improve long-term survival after oesophgaeal variceal bleeding. Lancet. 1983;2:1328-1332.
11. The Copenhagen esophageal variceal project. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. NEJM. 1984;311:1594-1600.
12. Soderlund C, Ihre T. Endoscopic sclerotherapy versus conservative management fo bleeding oesophageal varices. A 5 year prospective controlled trial of emergency and long term treatment. Acta Chir Scand. 1985;151:449-456.
13. Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology. 1985;5:580-583.
14. The Veteran's Affairs Cooperative Variceal Sclerotherapy Group. Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. Hepatology. 1994;20:618-625.
15. Kage M, Korula J, Harada A, et al. The effects of sodium tetradecyl sulfate esophageal variceal sclerotherapy on the esophagus: a prospective clinical and histopathological study. J Clin Gastro. 1987;9:635-643.
16. Chung RS, Dearlove J. The sources of recurrent hemorrhage during long term sclerotherapy. Surgery. 1988;104:687-696.
17. Pugh S, Lewis S, Smith PM. Bleeding oesophageal varices in alcoholic cirrhosis: long-term follow-up of endoscopic sclerotherapy. Q J Med. 1993;86:241-245.
18. Van Hootegem Ph, Van Besien K, Broeckaert L, et al. Endoscopic sclerotherapy of esophageal varices. Long-term follow-up, recurrence, and survival. J Clin Gastroenterol. 1988;10:368-372.
19. Sarin SK, Sachdev G, Nanda R. Follow up of patients after variceal eradication. A comparison of patients with cirrhosis, non cirrhotic portal fibrosis and extrahepatic obstruction. Ann Surg. 1986;204:78-82.
20. Hashizume M, Kitano S, Koyanagi N, et al. Endoscopic injection sclerotherapy for 1000 patients with esophageal varices: a nine year prospective study. Hepatology. 1992;15:69-75.
21. Kitano S, Terblanche J, Kahn D, Bornman PC. Venous anatomy of the lower oesophagus in portal hypertension: practical implications. Br J Surg. 1986;73:525-531.
22. Korula J, Chin K, Ko Y, Yamada S. The demonstration of two distinct subsets of gastric varices: observations during a seven year study of endoscopic variceal sclerotherapy. Dig Dis Sci. 1991;36:303-309.
23. Payen J-P, Cales P, Voigt J-J, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138-144.
24. Reynolds TB, Geller HM, Kuzma OT, Redeker AG. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. NEJM. 1960;263:734-739.